At My Concierge MD, we’re excited to offer cagrilintide injections as a cutting-edge weight loss solution. Whether used alone or alongside treatments like semaglutide and tirzepatide, cagrilintide is an innovative option for individuals seeking effective weight management solutions. Here, we’ll delve into how this remarkable therapy works, its potential benefits, and why it might be the right choice for you.
What is Cagrilintide?
Cagrilintide is a synthetic peptide created by Novo Nordisk, a company known for its work in healthcare. It’s being studied as a possible treatment for obesity and type 2 diabetes (T2D) [1]. The drug is based on amylin, a natural hormone the pancreas makes that helps control hunger and blood sugar levels.
Cagrilintide has been designed to improve its ability to bind to amylin receptors (AMYRs) and calcitonin receptors (CTRs), which are essential for controlling hunger and how much energy the body takes in. It also has a longer-lasting effect, meaning it can be injected once a week [2].
Semaglutide Weight Loss Special Promotion $999
3 Month Supply of Best Compounded Semaglutdie Injection ( Ozempic, Wegovy)
Tirzepatide Weight Loss Special Promotion $850
1 Month Supply of Best Compounded Tirzepatide Injection ( Mounjaro, Zepbound)
Includes
Virtual or In Person Office Visit with MD & Nutritionist
Lab Orders To Evaluate Health & Optimize Deficiencies
Cagrilintide works in several ways to help with weight loss:
Suppressing Hunger: By activating AMYRs and CTRs in the brain, cagrilintide reduces feelings of hunger. This happens in areas of the brain that control food intake, which helps people eat less [3].
Prolonging Fullness: Cagrilintide slows down how quickly food moves through the stomach and reduces glucagon (a hormone that raises blood sugar). This helps you feel fuller for longer and keeps blood sugar levels stable [4].
Improving Metabolic Health: The drug helps regulate calcium levels in the body, supporting better blood sugar control [5].
Cagrilintide in Combination with Semaglutide (CagriSema)
Cagrilintide can also be used with another drug called semaglutide. This combination, known as CagriSema, could be even more effective for treating obesity and type 2 diabetes. Early results from studies show that it leads to significant weight loss and better blood sugar control. Although it’s not yet approved by the FDA, it may be available soon [6, 7, 8].
The Benefits of Cagrilintide
Studies show that cagrilintide is effective for weight loss. In one trial, people with obesity who took cagrilintide once a week lost more weight than those taking a placebo or other treatments like liraglutide.
A 0.3 mg dose once a week led to an average 6% weight loss.
Higher doses, like 4.5 mg per week, resulted in up to 10.8% weight loss, much better than liraglutide [9].
This shows that cagrilintide could work alone or alongside other treatments.
Potential Side Effects and Considerations
As with any medication, there can be side effects. Some people may experience mild stomach issues like nausea or constipation, but these usually go away on their own. In clinical trials, only about 10% of people stopped using cagrilintide because of side effects [9].
Why Choose My Concierge MD for Cagrilintide Injections?
At My Concierge MD, we’re proud to stay at the forefront of medical advancements. Our personalized approach ensures that every treatment plan is tailored to your unique needs and goals. Whether you’re new to weight loss therapies or looking for an alternative after other treatments like semaglutide or tirzepatide have stopped working, cagrilintide might be the perfect solution for you.
Start Your Weight Loss Journey Today
Cagrilintide injections represent a promising option for individuals seeking to achieve their weight loss goals effectively and sustainably. Whether you’re considering it as a standalone therapy or in combination with other treatments, My Concierge MD is here to provide expert care and support.
Contact us today to schedule a consultation and learn more about how cagrilintide can help you achieve your weight loss and health goals.
References:
Eržen S, Tonin G, Jurišić Eržen D, Klen J. Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. Int J Mol Sci. 2024;25(3):1517. doi:10.3390/ijms25031517
Dehestani B, Stratford NR, le Roux CW. Amylin as a Future Obesity Treatment. J Obes Metab Syndr. 2021;30(4):320-325. doi:10.7570/jomes21071
Züger D, Forster K, Lutz TA, Riediger T. Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli. Physiol Behav. 2013;112-113:61-69. doi:10.1016/j.physbeh.2013.02.006
Boyle CN, Zheng Y, Lutz TA. Mediators of Amylin Action in Metabolic Control. J Clin Med. 2022;11(8):2207. doi:10.3390/jcm11082207
Larsen AT, Sonne N, Andreassen KV, Karsdal MA, Henriksen K. The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy. J Pharmacol Exp Ther. 2020;374(1):74-83. doi:10.1124/jpet.119.263392
Mikhail N, Wali S. Cagrilintide Combined with Semaglutide: A New Approach for Treatment of Obesity and Type 2 Diabetes. Clinical Trials and Clinical Research. 2023;2(5): DOI:10.31579/2834-5126/043
Melson E, Miras AD, Papamargaritis D. Future therapies for obesity. Clin Med (Lond). 2023;23(4):337-346. doi:10.7861/clinmed.2023-0144
Bailey CJ, Flatt PR, Conlon JM. Recent advances in peptide-based therapies for obesity and type 2 diabetes. Peptides. 2024;173:171149. doi:10.1016/j.peptides.2024.171149
Lau DCW, Erichsen L, Francisco AM, et al. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet. 2021;398(10317):2160-2172. doi:10.1016/S0140-6736(21)01751-7
